These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 761176)

  • 1. Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC).
    Rainey JM; Jones SE; Salmon SE
    Cancer; 1979 Jan; 43(1):66-71. PubMed ID: 761176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
    Carmo-Pereira J; Costa FO; Henriques E
    Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.
    Jones SE; Durie BG; Salmon SE
    Cancer; 1975 Jul; 36(1):90-7. PubMed ID: 1203853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
    Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA).
    Zekan PJ; Muss HB; Capizzi RL; Cooper MR; Harding RW; Hopkins JO; Jackson DV; Ramseur WL; Richards F; Spurr CL
    Cancer; 1984 Dec; 54(11):2338-43. PubMed ID: 6388802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy.
    Mattsson W; Arwidi A; von Eyben F; Lindholm CE
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(5):431-44. PubMed ID: 394576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer.
    Lloyd RE; Jones SE; Salmon SE
    Cancer; 1979 Jan; 43(1):60-5. PubMed ID: 153787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial.
    Gundersen S; Kvinnsland S; Klepp O; Kvaløy S; Lund E; Høst H
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1431-4. PubMed ID: 3595668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
    Abeloff MD; Ettinger DS
    Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of adriamycin and cyclophosphamide (alone or with other substances) in the treatment of breast cancer].
    Salmon SE; Jones SE
    Onkologie; 1979 Apr; 2(2):45-52. PubMed ID: 93257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
    Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
    Muss HB; Richards F; Jackson DV; Cooper MR; White DR; Stuart JJ; Ramseur W; Christian RM; Wells HB; Pope E; Spurr CL
    Cancer; 1982 Dec; 50(11):2269-74. PubMed ID: 6754062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.
    Oster MW; Park Y
    Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
    Mattsson W; Arwidi A; von Eyben F; Lindholm CE
    Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE; Nagel GA
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE; Powles TJ
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.